Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
4 Results for "
preceding
" in MedChemExpress (MCE) Product Catalog:
Products (4)
4 Results for "preceding" in MCE Product Catalog:
104
104 Cited Publications
Target:
Research Areas:
PLX5622 is a highly selective brain penetrant and orally active CSF1R inhibitor (IC50=0.016 μM; Ki=5.9 nM). PLX5622 allows for extended and specific microglial cells elimination, preceding and during pathology development. PLX5622 is an ideal choose for microglia function research in healthy or diseased states. PLX5622 has been verified by MedChemExpress, which demonstrates desirable microglia depletion efficiency in mice. PLX5622 is predominantly administered via ad libitum diets with a dose of 1200 ppm .
104
104 Cited Publications
Cat. No.: HY-114153A
Purity: 99.88%
Target:
Research Areas:
PLX5622 hemifumarate is a highly selective brain penetrant and orally active CSF1R inhibitor (IC50=0.016 μM; Ki=5.9 nM). PLX5622 hemifumarate allows for extended and specific microglial elimination, preceding and during pathology development. PLX5622 hemifumarate demonstrates desirable PK properties in varies animals .
Cat. No.: HY-114153R
CAS No.: 1303420-67-8
Target:
Research Areas:
PLX5622 (Standard) is the analytical standard of PLX5622 (HY-114153). This product is intended for research and analytical applications. PLX5622 is a highly selective brain penetrant and orally active CSF1R inhibitor (IC50=0.016 μM; Ki=5.9 nM). PLX5622 allows for extended and specific microglial cells elimination, preceding and during pathology development. PLX5622 is an ideal choose for microglia function research in healthy or diseased states. PLX5622 has been verified by MedChemExpress, which demonstrates desirable microglia depletion efficiency in mice. PLX5622 is predominantly administered via ad libitum diets with a dose of 1200 ppm .
Cat. No.: HY-P992564
Target:
Research Areas:
Anti-Human/Rat/Mouse CD36 Antibody (FA6-152) is a monoclonal antibody targeting GP IV (CD36) that impairs thrombospondin interactions and inhibits platelet aggregation/secretion. Anti-Human/Rat/Mouse CD36 Antibody (FA6-152) inhibits ADP-, collagen-, and thrombin-induced platelet aggregation and granule secretion, and inhibits the membrane surface display of thrombospondin on the platelet surface under thrombin stimulation. Anti-Human/Rat/Mouse CD36 Antibody (FA6-152) recognizes fetal erythrocyte antigens, labels early erythroid progenitors with antigen expression preceding glycophorin A, and recognizes monocytes, platelets, and mature megakaryocytes, while not binding to granulocytes or lymphocytes. Anti-Human/Rat/Mouse CD36 Antibody (FA6-152) can be used in research on platelet activation and aggregation and acute myeloid leukemia .
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
